We constantly invest our efforts in developing cutting-edge technologies to achieve the highest quality products. HYAcorp products are produced with a patented manufacturing process - The Advanced Thixotropic Technology (ATT).

The thixotropy process allows a special type of cross-linked hyaluronic acid gel to be synthesized. The gel gets the ability to become less viscous under pressure (injecting force) and immediately return to its original viscosity when the pressure is no longer applied. HYAcorp gel’s molecules are covalently bonded, meaning they remain in the tissue for longer and are more stable. The special structure of these molecules also reduces the diffusion rate of the enzyme hyaluronidase into the matrix resulting in a long-lasting gel.

Thixotropy-based products guarantee considerably better results in terms of increased volume, outstanding treatment goals and durable effects.

Constant research is key to our development. We conduct clinical trials and evaluations regularly to test and re-confirm that our medical devices are some of the safest ones in the market.

The latest prospective, multicentre observational clinical trial on HYAcorp has established it as a safe and quality solution for professionals. The PMCF study showed high level of patient satisfaction and minimal side effects with HYAcorp for gluteal augmentation.